CLINICAL STUDY: ACUTE CORONARY SYNDROMES
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes
A TACTICS-TIMI 18 substudy
Marc S. Sabatine, MD, MPH*,*,
David A. Morrow, MD, MPH*,
Christopher P. Cannon, MD*,
Sabina A. Murphy, MPH ,
Laura A. Demopoulos, MD ,
Peter M. DiBattiste, MD ,
Carolyn H. McCabe, BS*,
Eugene Braunwald, MD* and
C. Michael Gibson, MD, MS
* TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Womens Hospital, Boston, Massachusetts, USA
Harvard Clinical Research Institute, Boston, Massachusetts, USA
Merck and Co., West Point, Pennsylvania, USA
Manuscript received April 3, 2002;
revised manuscript received June 27, 2002,
accepted July 18, 2002.
* Reprint requests and correspondence: Dr. Marc S. Sabatine, Cardiovascular Division, Brigham and Womens Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. msabatine{at}partners.org
OBJECTIVES: This study was designed to determine the relationship between baseline white blood cell (WBC) count and angiographic and clinical outcomes in patients with unstable angina (UA)/nonST-segment elevation myocardial infarction (NSTEMI) and to see if WBC count was a significant predictor of outcomes independent of other biomarkers.
BACKGROUND: Inflammation has been shown to play a role in atherosclerosis and acute coronary syndromes.
METHODS: We evaluated the relationship between baseline WBC count, other baseline variables and biomarkers, angiographic findings, and clinical outcomes in 2,208 patients in the Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18 (TACTICS-TIMI 18) trial.
RESULTS: Higher baseline WBC counts were associated with lower Thrombolysis In Myocardial Infarction (TIMI) flow grades (p = 0.0045) and TIMI myocardial perfusion grades (p = 0.03) as well as a greater extent of coronary artery disease (CAD) (p < 0.0001). A higher baseline WBC count was predictive of higher six-month mortality, ranging from 1.5% to 3.6% to 5.1% for patients with low, intermediate, and high WBC counts, respectively (p = 0.0017). In a multivariable proportional hazards model, patients with a low C-reactive protein (CRP) but an elevated WBC remained at significantly higher risk of death at six months (hazard ratio [HR] 4.3, p = 0.049), and patients with a high CRP were at even higher risk (HR 8.6, p = 0.004).
CONCLUSIONS: In patients with UA/NSTEMI, elevations in a simple, widely available blood test, the WBC count, were associated with impaired epicardial and myocardial perfusion, more extensive CAD, and higher six-month mortality. After adjustment for traditional risk factors and other biomarkers, assessment of two inflammatory markers, WBC count and CRP, can be used to stratify patients across an eightfold gradation of six-month mortality risk.
|
Abbreviations and Acronyms
| | ACS | | acute coronary syndrome | | CAD | | coronary artery disease | | CRP | | C-reactive protein | | HR | | hazard ratio | | IL | | interleukin | | MI | | myocardial infarction | | NSTEMI | | nonST-segment elevation myocardial infarction | | OR | | odds ratio | | TACTICS | | Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy | | TFG | | Thrombolysis In Myocardial Infarction flow grade | | TIMI | | Thrombolysis In Myocardial Infarction | | TMPG | | Thrombolysis In Myocardial Infarction myocardial perfusion grade | | UA | | unstable angina | | WBC | | white blood cell |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Kumar and C. P. Cannon
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clin. Proc.,
October 1, 2009;
84(10):
917 - 938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf
CHAPTER 16 Acute Coronary Syndromes
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O'Donoghue, D. A. Morrow, C. P. Cannon, W. Guo, S. A. Murphy, C. M. Gibson, and M. S. Sabatine
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy
Eur. Heart J.,
April 2, 2008;
29(8):
984 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. George and M. C. Oz
Myocardial Revascularization after Acute Myocardial Infarction
Card. Surg. Adult,
January 1, 2008;
3(2008):
669 - 696.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
J. Exp. Med.,
November 26, 2007;
204(12):
3037 - 3047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sandek, J. Bauditz, A. Swidsinski, S. Buhner, J. Weber-Eibel, S. von Haehling, W. Schroedl, T. Karhausen, W. Doehner, M. Rauchhaus, et al.
Altered Intestinal Function in Patients With Chronic Heart Failure
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1561 - 1569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. C. Raffel, G. J. Tearney, D. D. Gauthier, E. F. Halpern, B. E. Bouma, and I.-K. Jang
Relationship Between a Systemic Inflammatory Marker, Plaque Inflammation, and Plaque Characteristics Determined by Intravascular Optical Coherence Tomography
Arterioscler Thromb Vasc Biol,
August 1, 2007;
27(8):
1820 - 1827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-F. Tse and C.-P. Lau
Therapeutic Angiogenesis With Bone Marrow--Derived Stem Cells
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2007;
12(2):
89 - 97.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lavi, A. Prasad, E. H. Yang, V. Mathew, R. D. Simari, C. S. Rihal, L. O. Lerman, and A. Lerman
Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease
Circulation,
May 22, 2007;
115(20):
2621 - 2627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Anwaruddin, A. T. Askari, and E. J. Topol
Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
279 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Gibson and C. M. Gibson
The association of impaired myocardial perfusion and monocytosis with late recovery of left ventricular function following primary percutaneous coronary intervention
Eur. Heart J.,
November 1, 2006;
27(21):
2487 - 2488.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mitchell, M. D. Brown, I. B.A. Menown, and J. A. Kline
Novel Protein Markers of Acute Coronary Syndrome Complications in Low-Risk Outpatients: A Systematic Review of Potential Use in the Emergency Department
Clin. Chem.,
November 1, 2005;
51(11):
2005 - 2012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Carter
Inflammation, thrombosis and acute coronary syndromes
Diabetes and Vascular Disease Research,
October 1, 2005;
2(3):
113 - 121.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nasir, E. Guallar, A. Navas-Acien, M. H. Criqui, and J. A.C. Lima
Relationship of Monocyte Count and Peripheral Arterial Disease: Results From the National Health and Nutrition Examination Survey 1999-2002
Arterioscler Thromb Vasc Biol,
September 1, 2005;
25(9):
1966 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nalivaiko, Y. Ootsuka, and W. W. Blessing
Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2005;
289(2):
R596 - R604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Abel, J. T. Hays, P. A. Decker, G. A. Croghan, D. J. Kuter, and N. A. Rigotti
Effects of Biochemically Confirmed Smoking Cessation on White Blood Cell Count
Mayo Clin. Proc.,
August 1, 2005;
80(8):
1022 - 1028.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kaski, P. Avanzas, R. Arroyo-Espliguero, and B. S. Coller
Neutrophil Count and Complex Lesions in Patients With Coronary Artery Disease
Arterioscler Thromb Vasc Biol,
June 1, 2005;
25(6):
e112 - e112.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A.H. Stewart, H. D. White, A. C. Kirby, S. R. Heritier, R. J. Simes, P. J. Nestel, M. J. West, D. M. Colquhoun, A. M. Tonkin, and for the Long-Term Intervention With Pravastatin in
White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin
Circulation,
April 12, 2005;
111(14):
1756 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Margolis, J. E. Manson, P. Greenland, R. J. Rodabough, P. F. Bray, M. Safford, R. H. Grimm Jr, B. V. Howard, A. R. Assaf, R. Prentice, et al.
Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women: The Women's Health Initiative Observational Study
Arch Intern Med,
March 14, 2005;
165(5):
500 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant.,
March 1, 2005;
20(3):
497 - 508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Madjid, I. Awan, J. T. Willerson, and S. W. Casscells
Leukocyte count and coronary heart disease: Implications for risk assessment
J. Am. Coll. Cardiol.,
November 16, 2004;
44(10):
1945 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Avanzas, R Arroyo-Espliguero, J Cosin-Sales, G Aldama, C Pizzi, J Quiles, and J C Kaski
Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes
Heart,
August 1, 2004;
90(8):
847 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman
Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm
Circulation,
June 24, 2003;
107(24):
2998 - 3002.
[Full Text]
[PDF]
|
 |
|
|